702 related articles for article (PubMed ID: 35385985)
41. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
Riegger C; Koeninger A; Hartung V; Otterbach F; Kimmig R; Forsting M; Bockisch A; Antoch G; Heusner TA
Acta Radiol; 2012 Dec; 53(10):1092-8. PubMed ID: 23002144
[TBL] [Abstract][Full Text] [Related]
42. A machine-learning-based combination of criteria to detect bladder cancer lymph node metastasis on [
Girard A; Dercle L; Vila-Reyes H; Schwartz LH; Girma A; Bertaux M; Radulescu C; Lebret T; Delcroix O; Rouanne M
Eur Radiol; 2023 Apr; 33(4):2821-2829. PubMed ID: 36422645
[TBL] [Abstract][Full Text] [Related]
43. Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer.
Ren C; Zhang F; Zhang J; Song S; Sun Y; Cheng J
Eur J Med Res; 2023 Dec; 28(1):554. PubMed ID: 38042812
[TBL] [Abstract][Full Text] [Related]
44. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
Wang M; Liu L; Dai Q; Jin M; Huang G
J Cancer Res Clin Oncol; 2023 Jan; 149(1):247-261. PubMed ID: 36565319
[TBL] [Abstract][Full Text] [Related]
45. The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
Choi WH; Yoo IR; O JH; Kim SH; Chung SK
Br J Radiol; 2011 Jul; 84(1003):593-9. PubMed ID: 21081574
[TBL] [Abstract][Full Text] [Related]
46. COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT.
Xu G; Lu Y
Clin Nucl Med; 2021 Apr; 46(4):353-354. PubMed ID: 33591026
[TBL] [Abstract][Full Text] [Related]
47. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on
El-Sayed MS; Wechie GN; Low CS; Adesanya O; Rao N; Leung VJ
Clin Med (Lond); 2021 Nov; 21(6):e633-e638. PubMed ID: 34862224
[TBL] [Abstract][Full Text] [Related]
48. Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma.
Gennari AG; Rossi A; Sartoretti T; Maurer A; Skawran S; Treyer V; Sartoretti E; Curioni-Fontecedro A; Schwyzer M; Waelti S; Huellner MW; Messerli M
Sci Rep; 2023 Oct; 13(1):18357. PubMed ID: 37884535
[TBL] [Abstract][Full Text] [Related]
49. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
Ahn JH; Son EJ; Kim JA; Youk JH; Kim EK; Kwak JY; Ryu YH; Jeong J
Acta Radiol; 2010 Oct; 51(8):859-65. PubMed ID: 20670083
[TBL] [Abstract][Full Text] [Related]
50. Clinical features and
Chen D; Zhu Y; Chen Y; Zhu D; Liu Z; Li T; Liu Y; Zhao K; Su X; Li L
BMC Infect Dis; 2022 Jul; 22(1):646. PubMed ID: 35896979
[TBL] [Abstract][Full Text] [Related]
51. Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.
Koolen BB; Valdés Olmos RA; Elkhuizen PH; Vogel WV; Vrancken Peeters MJ; Rodenhuis S; Rutgers EJ
Breast Cancer Res Treat; 2012 Aug; 135(1):231-40. PubMed ID: 22872522
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Traditional Radiomics, Deep Learning Radiomics and Fusion Methods for Axillary Lymph Node Metastasis Prediction in Breast Cancer.
Li X; Yang L; Jiao X
Acad Radiol; 2023 Jul; 30(7):1281-1287. PubMed ID: 36376154
[TBL] [Abstract][Full Text] [Related]
53. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
Smith MV; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
[TBL] [Abstract][Full Text] [Related]
54. Discordant results in
Parisse-Di Martino S; Faure C; Mognetti T
Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
[TBL] [Abstract][Full Text] [Related]
55. Progressive Transformation of Germinal Centers Simulating Malignant Axillary Lymphadenopathy in a Breast Cancer Patient on FDG PET/CT.
Hod N; Nalbandyan K; Porges T; Lantsberg S
Clin Nucl Med; 2023 Feb; 48(2):e89-e91. PubMed ID: 36607381
[TBL] [Abstract][Full Text] [Related]
56. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
57. Deep learning combined with radiomics for the classification of enlarged cervical lymph nodes.
Zhang W; Peng J; Zhao S; Wu W; Yang J; Ye J; Xu S
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2773-2780. PubMed ID: 35562596
[TBL] [Abstract][Full Text] [Related]
58. Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.
Quak E; Morel A; Faudemer J; Levy C; Ciappuccini R
Clin Nucl Med; 2022 Mar; 47(3):275-276. PubMed ID: 34661560
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake.
Eifer M; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Shams J; Keret N; Gorfine M; Eshet Y
J Nucl Med; 2022 Jan; 63(1):134-139. PubMed ID: 33893188
[TBL] [Abstract][Full Text] [Related]
60. A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [
Cohen D; Hazut Krauthammer S; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1338-1344. PubMed ID: 34651230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
